Diabetes Drugs May Ease Pulmonary Hypertension by Taming Activin A Signaling
A new study links SGLT2 inhibitor therapy with reduced circulating activin A, improved right-heart function, and modulation of BMP/activin signaling ...
A new study links SGLT2 inhibitor therapy with reduced circulating activin A, improved right-heart function, and modulation of BMP/activin signaling ...
Researchers have discovered that epigenetic silencing of the FCGR2A gene by promoter hypermethylation, driven by the transcription factor ATF3, worsens ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine